Aripiprazole Microspheres for Injection(Livzon Microsphere Tech)

注射用阿立哌唑微球（丽珠微球科技）

Report date: 2025/05/09 15:49:07

Base Information

Drug NameAripiprazole Microspheres for Injection(Livzon Microsphere Tech)
Drug Alias Name阿利哌唑阿立派唑注射用阿立哌唑微球（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor agonistsDopamine D4 receptor antagonists +[9] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[9] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2025/04/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhuhai Livzon Microsphere Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Livzon Microsphere Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG